Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer-Reference-Cited by-同舟云学术

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Published:2006-05 Issue: Volume:17 Page:v118-v122
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Roberts J.T.,von der Maase H.,Sengeløv L.,Conte P.F.,Dogliotti L.,Oliver T.,Moore M.J.,Zimmermann A.,Arning M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/17/suppl_5/v118/477551/mdj965.pdf

Reference14 articles.

1. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J Urol,1985

2. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Loehrer;J Clin Oncol,1992

3. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelial. Efficacy and patterns of response and relapse;Sternberg;Cancer,1989

4. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol,1997

5. Gemcitabine in transitional cell carcinoma of the urothelium;von der Maase;Expert Rev Anticancer Ther,2003

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk analysis of enfortumab vedotin: A real-world approach based on the FAERS database;Heliyon;2024-09

2. Adverse events in patients with advanced urothelial carcinoma treated with erdafitinib: a retrospective pharmacovigilance study;Frontiers in Pharmacology;2023-11-21

3. Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for muscle-invasive bladder cancer: case series;Annals of Medicine & Surgery;2023-11-20

4. Surgical Treatment of Solitary Metachronous Adrenal Metastasis from Urothelial Carcinoma of the Urinary Bladder;European Endocrinology;2023

5. Knockdown of ZBTB11 impedes R‐loop elimination and increases the sensitivity to cisplatin by inhibiting DDX1 transcription in bladder cancer;Cell Proliferation;2022-08-26